'Another chap I'm happy to declare a personal interest in is Paul Glasziou, safe and dry in Queensland and one of the best minds in medicine. Here he gets back together with Les Irwig and other Australian colleagues to look at the claim that regular monitoring of serum cholesterol in people taking statins is a good way of checking compliance. It isn't: it's irrational, anachronistic and a waste of time and money. Like at least half of the UK Quality and Outcomes Framework.' Download Research Paper - Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data (PDF 137KB)
